Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.
about
Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificityStructure of influenza hemagglutinin in complex with an inhibitor of membrane fusionCombining mutual information with structural analysis to screen for functionally important residues in influenza hemagglutininDynamic Viral Glycoprotein Machines: Approaches for Probing Transient States That Drive Membrane FusionCrystal structure of an anti-carbohydrate antibody directed against Vibrio cholerae O1 in complex with antigen: Molecular basis for serotype specificityCrystal structure of unliganded influenza B virus hemagglutinin.Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobilityThe complete influenza hemagglutinin fusion domain adopts a tight helical hairpin arrangement at the lipid:water interfaceThe Receptor-Binding Domain of Influenza Virus Hemagglutinin Produced in Escherichia coli Folds into Its Native, Immunogenic StructureStructural Characterization of an Early Fusion Intermediate of Influenza Virus HemagglutininHeterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidityHuman antibodies that neutralize respiratory droplet transmissible H5N1 influenza virusesAntibody Recognition of the Pandemic H1N1 Influenza Virus Hemagglutinin Receptor Binding SiteReceptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virusRefined structures of bobwhite quail lysozyme uncomplexed and complexed with the HyHEL-5 Fab fragmentAntigen distortion allows influenza virus to escape neutralizationMembrane fusion mechanisms: the influenza hemagglutinin paradigm and its implications for intracellular fusion.Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics.Virus neutralisation: new insights from kinetic neutralisation curvesLarge-scale analysis of B-cell epitopes on influenza virus hemagglutinin - implications for cross-reactivity of neutralizing antibodies.Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in miceEfficacious recombinant influenza vaccines produced by high yield bacterial expression: a solution to global pandemic and seasonal needs.Influenza viruses with receptor-binding N1 neuraminidases occur sporadically in several lineages and show no attenuation in cell culture or mice.Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses.Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targetsVaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.Predicting interaction sites from the energetics of isolated proteins: a new approach to epitope mapping.Bacterial HA1 vaccine against pandemic H5N1 influenza virus: evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets.Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades.Structural basis of influenza virus neutralization.Screening of random peptide library of hemagglutinin from pandemic 2009 A(H1N1) influenza virus reveals unexpected antigenically important regions.Passive immune neutralization strategies for prevention and control of influenza A infections.Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza viruses.Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptationEmerging antiviral strategies to interfere with influenza virus entry.pH-induced conformational changes of membrane-bound influenza hemagglutinin and its effect on target lipid bilayers.Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: implications for fusion activation.Relating influenza virus membrane fusion kinetics to stoichiometry of neutralizing antibodies at the single-particle levelAnalysis of the subunit stoichiometries in viral entry.Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against influenza A M2 protein.
P2860
Q24646829-4FE869A3-B7DB-4A23-BAAF-D19F26B8FFB3Q24656213-6082CBC6-2E22-4BB1-A1C1-23B51D887BB2Q24657504-66E1CE32-6EDD-4758-A634-6D40622EE3EAQ26772129-D8E4086E-0698-416F-A831-264CD3F5D8BAQ27625180-EE09FF81-95AF-4699-801D-F4218ED149CFQ27649507-444D9F47-8C51-4996-A03B-EC18D3ABF398Q27658989-EEDB49A4-3F47-469D-8132-E59751F6AFE3Q27662151-85553AC8-6D5C-4176-A2DB-D6AD59B3E0D7Q27665742-8720A033-1415-4D1A-AB9A-FDA2B66405C1Q27667137-0D42224D-4DE2-42B3-AA65-7F09DF74DD2EQ27673861-A82EFA12-2EDE-4E65-A487-A6E4E626ED47Q27679859-B3A0AA6B-885A-45AE-8A80-8A0B00656F54Q27679927-D19E9213-D5A8-4B46-AB1C-FB0AC2A70FBFQ27683156-1189E0B4-447D-43B1-8971-96AA0BE2F4FEQ27733724-42A00F61-6CB1-45AC-A13A-A71B97D96ED3Q27748841-1BB06137-5128-47DE-A32A-763B615B8C55Q27863691-24D2206E-F137-43F0-AE19-ED8B36302A21Q28345849-783A5D67-236E-4510-8BED-6611654F4FF1Q28487427-EEB7EB35-AFBA-4093-A573-A1AC87C19577Q30217235-EC90EF0E-B05B-4E78-8D90-518B72A4D5F6Q30357432-6F91EA3E-72B4-4978-BC2C-30E480A213CAQ30369510-6E87BF57-FA51-4389-BB08-8F8AB5DCE6D1Q30370985-AF0C9572-CC1F-44F8-A0B0-F12B739D13C2Q30370987-F800A5E4-2555-4444-8463-0E6AF6C9D1B9Q30376292-C31423F7-A17C-4D89-BEEA-3EBE34DA87EEQ30387739-28787077-FA0C-4D8E-9A6D-21EB911F9BC3Q30388806-97BD7CCD-BA60-40E8-A738-BFAA00DB0FCDQ30396343-17030084-55DF-44FB-B8DC-93B8A05B9A6FQ30397107-298C0F58-7BEC-43D8-A4CA-B0DF23F73C1BQ30398754-EEB5EA6C-AB62-4354-A18A-885D911C7333Q30401148-07A1E309-DB92-4575-8EB6-DC26B9F16447Q30413158-F6643E13-B046-419C-866C-1CFB60F14AC2Q30419865-2987DDB9-BDEB-4588-87D0-01CA1F78FF85Q30427818-78914391-377B-4D0F-90EA-D4277F9FA378Q30432421-67B6FEBE-2D69-448C-972D-8ABCEDE34D24Q30444021-FBCBE95F-2CCC-4793-B741-802AFBB00CCDQ30448472-C9CC23E2-4853-47D1-BCAE-EAC36F499DB8Q30606286-E54F0547-B4D5-4C79-98D8-CC2293037277Q31053897-A8EC7DD0-C230-4A61-A65B-F5C9E3770B46Q33582945-E0D18678-E8E6-4B8A-8112-60D8E9B3FF1D
P2860
Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.
@en
Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.
@nl
type
label
Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.
@en
Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.
@nl
prefLabel
Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.
@en
Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.
@nl
P2093
P50
P356
P1433
P1476
Structure of influenza virus haemagglutinin complexed with a neutralizing antibody
@en
P2093
P2888
P356
10.1038/376092A0
P407
P577
1995-07-01T00:00:00Z
P6179
1023024876